Mounjaro 5mg KwikPen contains Tirzepatide 5 mg per dose in a 2.4 mL multi-dose prefilled pen. It is a prescription injectable medicine used under medical supervision to help improve blood sugar control in patients with type 2 diabetes mellitus, along with diet, exercise, and lifestyle management as advised by a healthcare professional. Tirzepatide is a dual GIP and GLP-1 receptor agonist. It works by helping the body release insulin when blood sugar levels are high, reducing excess sugar release from the liver, slowing stomach emptying, and supporting better blood glucose control when used as prescribed. Mounjaro 5mg KwikPen is designed for once-weekly subcutaneous injection. Each KwikPen contains 4 fixed doses, with one dose taken each week. It should be used only as directed by your doctor, nurse, or trained healthcare professional.

Key Features

• Contains Tirzepatide 5 mg: A dual GIP and GLP-1 receptor agonist used for type 2 diabetes management.
• Multi-Dose KwikPen: Contains 4 fixed weekly doses in one prefilled pen.
• Once-Weekly Use: Designed for one subcutaneous injection per week as prescribed.
• Supports Blood Sugar Control: Helps improve glycemic control when combined with diet and exercise.
• Prescription-Only Injection: Should be used only under medical supervision.

Active Ingredient

• Tirzepatide 5 mg per dose: A dual GIP and GLP-1 receptor agonist used to support blood sugar control in type 2 diabetes mellitus.

How to Use

• Use Mounjaro 5mg KwikPen exactly as prescribed by your doctor.
• Inject once weekly under the skin, usually in the abdomen, thigh, or upper arm as advised.
• Use a new pen needle for each injection.
• Do not inject into a vein or muscle.
• Use it on the same day each week for better routine adherence.
• Do not share your KwikPen with anyone, even if the needle has been changed.
• After completing 4 doses, dispose of the pen safely as instructed by your healthcare provider.
• Do not change the dose or stop using this medicine without consulting your doctor.

Precautions

• Use only under the supervision of a qualified healthcare professional.
• Inform your doctor if you have pancreas problems, kidney disease, liver disease, stomach emptying problems, gallbladder disease, or diabetic eye disease.
• Tell your doctor if you are pregnant, planning a pregnancy, or breastfeeding.
• Inform your healthcare provider about all diabetes medicines, insulin, prescription medicines, OTC products, vitamins, and supplements you are using.
• Monitor blood sugar levels regularly as advised by your doctor.
• This medicine is not intended for type 1 diabetes or diabetic ketoacidosis.

Warning

• Possible side effects may include nausea, vomiting, diarrhea, constipation, stomach pain, reduced appetite, indigestion, bloating, or injection-site reactions.
• Seek medical help immediately if you develop severe abdominal pain, persistent vomiting, dehydration, allergic reaction, swelling, breathing difficulty, or signs of pancreatitis.
• Do not use this medicine if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 unless your doctor confirms it is appropriate.
• The risk of low blood sugar may increase when used with insulin or sulfonylurea medicines.
• This medicine should not be used as a cosmetic weight-loss product.
• Use only as directed by your healthcare provider.

Storage

• Store in a refrigerator as directed on the product label.
• Do not freeze the pen.
• Protect from direct sunlight and excessive heat.
• Keep the pen cap on when not in use.
• Keep out of reach of children and pets.
• Do not use if the solution appears cloudy, discolored, frozen, or contains particles.

Legal Disclaimer: Mounjaro 5mg KwikPen is a prescription injectable medicine and should be used only under the supervision of a qualified healthcare professional. This information is provided for educational and product information purposes only and should not replace professional medical advice, diagnosis, or treatment. Always follow your doctor’s instructions before using this medicine.

The post Mounjaro 5mg KwikPen (Tirzepatide Injection 2.4 ml) appeared first on PMC Herbals.